This week I’ll discuss only one letter – from Pfizer’s CEO Dr. Albert Bourla. The reason I decided to focus on Pfizer’s letter is because it’s head and shoulders above other letters I’ve read over the past week - a true Outlier. Here is Dr. Bourla: While I don’t have a strong view about whether Burla is an outstanding CEO (I have not done enough work yet), there are several signs pointing this might be the case:
Shareholder letters: Pfizer
Shareholder letters: Pfizer
Shareholder letters: Pfizer
This week I’ll discuss only one letter – from Pfizer’s CEO Dr. Albert Bourla. The reason I decided to focus on Pfizer’s letter is because it’s head and shoulders above other letters I’ve read over the past week - a true Outlier. Here is Dr. Bourla: While I don’t have a strong view about whether Burla is an outstanding CEO (I have not done enough work yet), there are several signs pointing this might be the case: